drugset / Trial / NCT06107400
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
Phase 0
Recruiting
5 enrolled
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Guangzhou Reforgene Medicine Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of RM-004 for Hemoglobin H-Constant Spring disease.
Timeline
- Start
- 2023-10-08
- Primary completion
- 2025-10-31
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RM-004 | Cell therapy | — | Intravenous |